However, in tumours of haematopoietic origin—diffuse large B‐cell lymphoma (DLBC) and acute myeloid leukaemia (LAML)—a higher IP‐to‐CP expression was observed, which can be explained by the innate IP expression in haematopoietic cells. The gene discussed is CP; the disease is acute myeloid leukemia.